Bliretrigine

Modify Date: 2025-09-10 21:33:24

Use of Bliretrigine

Bliretrigine is a sodium channel blocker. Bliretrigine has the effect of relieving pain[1][2][3].

Name	Bliretrigine

Description	Bliretrigine is a sodium channel blocker. Bliretrigine has the effect of relieving pain[1][2][3].
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> Sodium Channel Research Areas >> Neurological Disease
References	[1]. WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022. [2]. Yoshihiro OYAMADA, et al. External medicinal preparation containing N2-{[1-ethyl-6-(4-methylphenoxy)-1H-benzimidazol-2-yl]methyl}-L-alanineamide for treating and/or preventing peripheral neuropathic pain. Patent AU2019306705. [3]. Hironori Kinoshita, et al. Preparation of N2-[(benzimidazol-2-yl or imidazo[4,5-b]pyridin-2-yl)methyl]amino acid amide derivatives as inhibitors of sensory neuron specific sodium channel (SNS). Patent AU2009331179.

Description

Bliretrigine is a sodium channel blocker. Bliretrigine has the effect of relieving pain[1][2][3].

Related Catalog

Signaling Pathways >> Membrane Transporter/Ion Channel >> Sodium Channel

Research Areas >> Neurological Disease

References

Molecular Formula	C₂₀H₂₄N₄O₂
Molecular Weight	352.43